HighGravityDataMicrochip Technology — Nov 6, 2025 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000827054-25-000182
Showing in the filing
Net (loss) income attributable to common stockholders (Non-GAAP)
“$193.0 to $227.4 million”
Period
Q3 FY2026
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 25
Net sales for Q3 FY2026
“$1.129 billion plus or minus $20 million”
Quarterly dividend on common stock
“45.5 cents per share”
Quarterly dividend on Series A Mandatory Con… for FY2025
“$18.750 per share (which represents $0.9375 per depositary share)”
Gross Profit (GAAP) for Q3 FY2026
“56.2% to 58.1%”
Gross Profit (Non-GAAP) for Q3 FY2026
“57.2% to 59.2%”
Operating Expenses (GAAP) for Q3 FY2026
“47.9% to 48.5%”
Operating Expenses (Non-GAAP) for Q3 FY2026
“32.3% to 32.7%”
Operating Income (GAAP) for Q3 FY2026
“7.7% to 10.3%”
Operating Income (Non-GAAP) for Q3 FY2026
“24.5% to 26.9%”
Other Expense, net (GAAP) for Q3 FY2026
“$55.9 to $56.5 million”
Other Expense, net (Non-GAAP) for Q3 FY2026
“$55.7 to $56.7 million”
Income Tax Provision (GAAP) for Q3 FY2026
“$14.6 to $24.9 million”
Income Tax Provision (Non-GAAP) for Q3 FY2026
“$22.0 to $26.0 million”
Net income (GAAP) for Q3 FY2026
“$14.6 to $37.3 million”
Net income (Non-GAAP) for Q3 FY2026
“$193.0 to $227.4 million”
Dividends on Series A Preferred Stock (GAAP) for Q3 FY2026
“$(27.8) million”
Net (loss) income attributable to common sto… for Q3 FY2026
“$(13.2) to $9.5 million”
Net (loss) income attributable to common sto… for Q3 FY2026
“$193.0 to $227.4 million”
Diluted Common Shares Outstanding (GAAP) for Q3 FY2026
“Approximately 540.8 to 545.2 million shares”
Diluted Common Shares Outstanding (Non-GAAP) for Q3 FY2026
“Approximately 568.3 to 569.3 million shares”
Diluted net (loss) income per common share (… for Q3 FY2026
“$(0.02) to $0.02”
Diluted net (loss) income per common share (… for Q3 FY2026
“$0.34 to $0.40”
Capital expenditures for FY2025
“between $15 million and $25 million”
Capital expenditures for FY2026
“at or below $100 million”
Assumed average stock price for FY2025
“between $60 and $70 per share”
Exhibit 99.1 · the passage around this item
… earlier in the release
Microchip Consolidated Guidance Net Sales $1.109 to $1.149 billion GAAP (5) Non-GAAP Adjustments (1) Non-GAAP (1) Gross Profit 56.2% to 58.1% $11.1 to $12.1 million 57.2% to 59.2% Operating Expenses (2) 47.9% to 48.5% $174.9 to $178.9 million 32.3% to 32.7% Operating Income 7.7% to 10.3% $186.0 to $191.0 million 24.5% to 26.9% Other Expense, net $55.9 to $56.5 million $(0.2) to $0.2 million $55.7 to $56.7 million Income Tax Provision $14.6 to $24.9 million (3) $1.1 to $7.4 million $22.0 to $26.0 million (4) Net income $14.6 to $37.3 million $178.4 to $190.1 million $193.0 to $227.4 million Dividends on Series A Preferred Stock $(27.8) million $27.8 million — Net (loss) income attributable to common stockholders $(13.2) to $9.5 million $206.2 to $217.9 million $193.0 to $227.4 million Diluted Common Shares Outstanding Approximately 540.8 to 545.2 million shares 24.1 to 27.5 million shares Approximately 568.3 to 569.3 million shares Diluted net (loss) income per common share $(0.02) to $0.02 $0.36 to $0.38 $0.34 to $0.40 (1) See the "Use of Non-GAAP Financial Measures" section of this release for information regarding our non-GAAP guidance. (2) We are not able to estimate the amount of certain Special Charges and Other, net that may be incurred during the quarter ending December 31, 2025. Therefore, our estimate of GAAP operating expenses excludes certain amounts that may be recognized as Special Charges and Other, net in the quarter ending December 31, 2025. (3) The forecast for GAAP tax expense excludes any unexpected tax events that may occur during the quarter, as these amounts cannot be forecasted. (4) Represents the expected cash tax rate for fiscal 2026, excluding any transition tax payments associated with the Tax Cuts and Jobs Act. (5) Our GAAP guidance excludes the impact of any potential gains or charges related to our ongoing evaluation of restructuring activities including the sale of our Fab 2 wafer fabrication facility. Capital expenditures for t
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.